Johnson & Johnson’s subsidiary Janssen Pharmaceuticals and ViiV Healthcare have revealed 48 week data from two pivotal Phase III trials showing injections of their long-acting, monthly combination of cabotegravir and...
8 March 2019 News
6 March 2019 Comment
PVX108 is a novel intradermal immunotherapy vaccine in a clinical trial for in peanut allergic individuals.
5 March 2019 News
A second patient has been cleared of the most aggressive, common form of human immunodeficiency virus (HIV), HIV-1 following a bone marrow transplant from a donor with a rare genetic...
18 February 2019 Comment
Globally, there are 633 marketed products for allergic conjunctivitis.
15 January 2019 Comment
Despite positive data observed with Catalyst Pharmaceuticals’ Firdapse in a proof-of-concept investigator-sponsored trial in muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG), the results’ clinical relevance is hard to determine.
18 December 2018 Comment
Chimerix’s oral CMX001 (brincidofovir) may increase the risk of diarrhoea for paediatric patients with adenovirus after allogeneic hematopoietic cell transplant (HCT), although a positive Phase II trial outcome is ultimately expected.
11 December 2018 Comment
The Ebola outbreak that began in August in the Democratic Republic of Congo (DRC) has now reached over 400 cases, becoming the second largest outbreak in history according to the...
3 December 2018 News
Procter & Gamble (P&G) has completed its acquisition of Merck’s Consumer Health business in a €3.4bn ($3.8bn) deal.